Insider Transactions in Q3 2024 at Broadridge Financial Solutions, Inc. (BR)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+1.28%
|
-
|
|
Sep 23
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
166
+0.66%
|
-
|
|
Sep 23
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+5.98%
|
-
|
|
Sep 23
2024
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+3.74%
|
-
|
|
Sep 23
2024
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+1.97%
|
-
|
|
Sep 10
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
17,534
-25.87%
|
$3,734,742
$213.41 P/Share
|
|
Sep 06
2024
|
Richard J Daly Executive Chairman |
SELL
Open market or private sale
|
Direct |
21,938
-9.02%
|
$4,541,166
$207.66 P/Share
|
|
Sep 06
2024
|
Richard J Daly Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
14,510
+10.25%
|
$1,697,670
$117.34 P/Share
|
|
Aug 26
2024
|
Leslie A Brun Director |
SELL
Open market or private sale
|
Direct |
5,739
-6.91%
|
$1,205,190
$210.05 P/Share
|
|
Aug 26
2024
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,445
+10.21%
|
$425,025
$45.09 P/Share
|
|
Aug 23
2024
|
Timothy C Gokey CEO |
SELL
Open market or private sale
|
Direct |
25,000
-10.81%
|
$5,225,000
$209.31 P/Share
|
|
Aug 23
2024
|
Timothy C Gokey CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,674
+11.71%
|
$1,564,374
$51.95 P/Share
|
|
Aug 21
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
6,501
-8.75%
|
$1,365,210
$210.22 P/Share
|
|
Aug 21
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,005
+8.62%
|
$1,036,740
$148.07 P/Share
|
|
Aug 19
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
162
-0.24%
|
$34,020
$210.0 P/Share
|
|
Aug 19
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+0.26%
|
$25,900
$148.07 P/Share
|
|
Aug 16
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
300
-0.44%
|
$63,000
$210.0 P/Share
|
|
Aug 16
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+0.48%
|
$47,804
$148.07 P/Share
|
|
Aug 16
2024
|
Timothy C Gokey CEO |
SELL
Open market or private sale
|
Direct |
25,000
-11.08%
|
$5,225,000
$209.11 P/Share
|
|
Aug 16
2024
|
Timothy C Gokey CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,675
+11.97%
|
$1,564,425
$51.95 P/Share
|
|
Aug 15
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
200
-0.3%
|
$42,000
$210.15 P/Share
|
|
Aug 15
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
216
+0.32%
|
$31,968
$148.07 P/Share
|
|
Aug 14
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
31,539
-11.95%
|
$6,528,573
$207.31 P/Share
|
|
Aug 14
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
34,326
+11.52%
|
$4,634,010
$135.62 P/Share
|
|
Aug 13
2024
|
Thomas P Carey Corporate VP |
BUY
Grant, award, or other acquisition
|
Direct |
5,116
+26.11%
|
-
|
|
Aug 13
2024
|
Richard J Daly Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
1,239
+1.09%
|
-
|
|
Aug 13
2024
|
Douglas Richard Deschutter Co-President ICS |
BUY
Grant, award, or other acquisition
|
Direct |
1,782
+5.04%
|
-
|
|
Aug 13
2024
|
Ashima Ghei Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
455
+11.34%
|
-
|
|
Aug 13
2024
|
Timothy C Gokey CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,381
+13.09%
|
-
|
|
Aug 13
2024
|
Laura Matlin CVP, Deputy GC and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
588
+8.77%
|
-
|
|
Aug 13
2024
|
Christopher John Perry President |
BUY
Grant, award, or other acquisition
|
Direct |
8,139
+11.22%
|
-
|
|
Aug 13
2024
|
Richard John Stingi Corporate VP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,860
+22.17%
|
-
|
|
Aug 08
2024
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Open market or private sale
|
Direct |
673
-10.85%
|
$145,368
$216.0 P/Share
|
|
Jul 05
2024
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.39%
|
-
|
|
Jul 05
2024
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.15%
|
-
|
|
Jul 05
2024
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.39%
|
-
|
|
Jul 05
2024
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.35%
|
-
|
|
Jul 05
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.19%
|
-
|
|
Jul 05
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.13%
|
-
|
|
Jul 05
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.16%
|
-
|
|
Jul 05
2024
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.18%
|
-
|
|
Jul 05
2024
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.18%
|
-
|